This shows you the differences between two versions of the page.
Previous revision | |||
— | home:publications:albert_autoimmunity_2010 [07.04.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Poster - Web 2.0 offers new opportunities for patient care and research ====== | ||
+ | |||
+ | |||
+ | **Type:** Conference presentation\\ | ||
+ | **Presenter: | ||
+ | **Conference: | ||
+ | **Location: | ||
+ | **Date: | ||
+ | **Additional Content: | ||
+ | |||
+ | |||
+ | |||
+ | ===== Abstract ===== | ||
+ | |||
+ | One of the most obvious means for bridging the gap between bench and bedside is the social Internet, also known as Web 2.0. As web services devoted to medical therapies figure more prominently in patients' | ||
+ | |||
+ | Web 2.0 is also shifting the nature of research. The commercial site PatientsLikeMe.com data-mines patient reports on behalf of pharmaceutical manufacturers. Non-profits like Autoimmunity Research Foundation use patient self-reports to improve the clarity and substance of treatment guidelines, and to qualitatively assess how a treatment under study affects different disease states. | ||
+ | |||
+ | The primary deficiencies of web-based patient reporting include issues related to anonymity, lack of accountability, | ||
+ | |||
+ | While these challenges need to be overcome, virtual communities offer viable methods for encouraging treatment compliance, recruiting participants, | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | | ||
+ | {{tag> | ||